IceCure Medical
ICCM • NASDAQ
IceCure Medical is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Eyal Shamir, with a market cap of $27.4M.
CEOEyal Shamir
Next Earnings
Upcoming earnings announcement for IceCure Medical
Date
Wednesday, May 27, 2026 (in 2 months)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.03
Revenue Estimate
$1.7M
Earnings History
Past 12 earnings reports for IceCure Medical
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q4 2025 | -$0.06Est: -$0.04 | -50.0% | $1.3MEst: $1.3M | -1.6% | — |
| Nov 19, 2025 | Q3 2025 | -$0.06Est: -$0.05 | -20.0% | $850.0KEst: $714.0K | +19.0% | — |
| Aug 13, 2025 | Q2 2025 | -$0.06Est: -$0.06 | 0.0% | $525.0KEst: $717.5K | -26.8% | — |
| May 28, 2025 | Q1 2025 | -$0.06Est: -$0.08 | +25.0% | $725.0KEst: $750.0K | -3.3% | — |
| Mar 27, 2025 | Q4 2024 | -$0.08Est: -$0.07 | -14.3% | $875.0KEst: $1.1M | -18.2% | — |
| Nov 26, 2024 | Q3 2024 | -$0.08Est: -$0.08 | 0.0% | $662.0KEst: $708.5K | -6.6% | — |
| Aug 20, 2024 | Q2 2024 | -$0.06Est: -$0.07 | +14.3% | $1.0MEst: $930.0K | +8.7% | — |
| May 28, 2024 | Q1 2024 | -$0.08Est: -$0.08 | 0.0% | $743.0KEst: $880.0K | -15.6% | — |
| Apr 3, 2024 | Q4 2023 | -$0.07Est: -$0.07 | 0.0% | $1.3MEst: $1.2M | +7.3% | — |
| Nov 15, 2023 | Q3 2023 | -$0.09Est: -$0.07 | -28.6% | $327.0KEst: $1.2M | -72.1% | — |
| Aug 14, 2023 | Q2 2023 | -$0.09Est: -$0.09 | 0.0% | $937.0KEst: $940.0K | -0.3% | — |
| May 22, 2023 | Q1 2023 | -$0.08Est: -$0.09 | +11.1% | $710.0KEst: $960.0K | -26.0% | — |